+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bioreactors Market - Global Forecast 2026-2032- Product Image
Bioreactors Market - Global Forecast 2026-2032- Product Image
Sale

Bioreactors Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083206
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bioreactors Market is projected to reach USD 14.62 Billion in 2026. It is expected to continue growing at a CAGR of 7.12%, reaching USD 22.21 Billion by 2032.

Bioreactors are the controlled production engines behind modern biopharmaceutical manufacturing, cell and gene therapy, vaccines, industrial enzymes, alternative proteins, and advanced fermentation. Demand is being shaped by the shift from small-molecule drugs to complex biologics, where living cells require precise control of pH, dissolved oxygen, agitation, temperature, sterility, and nutrient delivery.

The landscape is advancing through single-use bioreactors, stainless-steel systems, perfusion platforms, microbial fermenters, and automated process-control software. Adoption is supported by expanding biologics pipelines, biosimilar production, pandemic preparedness investments, and the need for flexible, GMP-compliant manufacturing capacity across global supply chains.

Transformative Shifts in the Bioreactors Landscape

The bioreactors landscape is shifting from fixed, large-scale stainless-steel infrastructure toward flexible, modular, and digitally monitored manufacturing. Single-use bioreactors continue to gain adoption in clinical and commercial biomanufacturing because they reduce cleaning validation, shorten changeover times, and lower cross-contamination risk, particularly for multiproduct facilities.

At the same time, intensified processing is redefining productivity. Perfusion bioreactors, high-density cell culture, continuous manufacturing, and closed-system designs are helping manufacturers improve yield, facility utilization, and batch consistency. These shifts are especially important as monoclonal antibodies, recombinant proteins, viral vectors, mRNA platforms, and cell therapies create more diverse production requirements.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is increasingly influencing bioreactor operations through predictive process control, soft sensors, anomaly detection, and digital twins. AI models can analyze process data from pH, dissolved oxygen, viable cell density, metabolite, temperature, pressure, and feed-rate signals to identify deviations earlier than manual monitoring, supporting improved batch success and quality-by-design strategies.

The cumulative impact is strongest when AI is combined with automation, process analytical technology, electronic batch records, and validated data-management systems. Manufacturers can use machine learning to optimize feeding strategies, forecast scale-up risks, improve root-cause analysis, and reduce development timelines. However, adoption depends on high-quality datasets, regulatory explainability, cybersecurity controls, data integrity, and alignment with GMP documentation requirements.

Key Regional Insights Across Bioreactor Markets

Asia-Pacific is expanding rapidly as China, India, Japan, South Korea, Singapore, and Australia invest in biosimilars, vaccines, contract manufacturing, and cell therapy infrastructure. China’s biopharmaceutical ecosystem is scaling through domestic innovation and government-backed manufacturing capacity, while India remains a major supplier of vaccines and biosimilars with growing demand for cost-efficient bioreactor systems. Japan emphasizes quality-led biologics and regenerative medicine, South Korea has strengthened its position in large-scale biologics contract manufacturing, and Australia supports translational research, clinical-stage bioprocessing, and advanced therapy development.

North America remains a leading hub due to strong biologics research, FDA-regulated manufacturing, venture-backed biotechnology pipelines, and advanced contract development and manufacturing capacity in the United States and Canada. Europe benefits from established pharmaceutical manufacturing in Germany, France, Italy, Spain, and the United Kingdom, supported by stringent quality oversight, skilled engineering capabilities, and sustainability requirements. Latin America is led by Brazil and Mexico in vaccines, biosimilars, and public health manufacturing, while the Middle East is building localized pharmaceutical and vaccine capacity through healthcare diversification agendas. Africa is increasingly focused on regional vaccine manufacturing, technology transfer, and biologics access to improve health security and reduce import dependence.

Key Group Insights for Bioreactor Demand

ASEAN is gaining importance as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines strengthen biopharma investment, vaccine fill-finish, clinical manufacturing, and regional supply resilience. Singapore remains a high-value biomanufacturing and process development hub, while larger ASEAN economies are using healthcare demand, industrial policy, and skilled workforce programs to attract localized production. The GCC is developing pharmaceutical localization strategies, with Saudi Arabia and the United Arab Emirates emphasizing life sciences clusters, vaccine security, technology transfer, and advanced healthcare infrastructure.

The European Union remains central to GMP harmonization, biologics quality standards, pharmacovigilance, and sustainable manufacturing policy, creating a strong environment for bioreactor adoption in regulated production. BRICS countries are important for scalable biosimilar, vaccine, and biologics demand, with China, India, and Brazil playing prominent roles in manufacturing expansion and public health supply. G7 markets lead in high-value biologics innovation, advanced therapy development, regulatory science, and automation adoption, while NATO-aligned countries benefit from coordinated investments in medical readiness, supply-chain security, and biodefense-related biomanufacturing.

Key Country Insights Shaping Bioreactor Adoption

The United States leads in biologics innovation, contract development and manufacturing capacity, FDA-compliant production, and advanced cell and gene therapy manufacturing, while Canada is strengthening biomanufacturing resilience through public and private investment in vaccines, biologics, and domestic production infrastructure. Mexico is increasingly relevant for nearshoring, pharmaceutical supply-chain diversification, and regional manufacturing integration, and Brazil anchors Latin American demand through vaccines, biosimilars, public-sector healthcare needs, and established immunization infrastructure.

In Europe, the United Kingdom supports biotechnology discovery, clinical translation, and advanced therapy manufacturing; Germany leads in engineering, automation, bioprocess equipment, and high-quality pharmaceutical production; France maintains strong biologics and vaccine capabilities; Italy and Spain contribute established pharmaceutical manufacturing and contract production capacity; and Russia focuses on domestic biologics supply and import substitution. In Asia-Pacific, China is scaling biomanufacturing rapidly through biosimilars, vaccines, and biologics innovation; India is expanding biosimilar and vaccine production with cost-efficient manufacturing strengths; Japan emphasizes high-quality biologics, regenerative medicine, and precision bioprocessing; South Korea is a major biologics contract manufacturing hub; and Australia supports clinical-stage biotechnology, translational research, and cell therapy development.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize flexible facility designs that combine single-use bioreactors, scalable stainless-steel capacity, closed processing, and modular automation. This approach supports faster technology transfer, multiproduct manufacturing, contamination control, and improved responsiveness to demand changes across biologics, biosimilars, vaccines, and advanced therapies.

Firms should also invest in data integrity, process analytical technology, supplier qualification, and workforce training. Strategic partnerships with contract manufacturers, equipment specialists, and automation vendors can reduce scale-up risk. Organizations that validate AI-enabled monitoring, strengthen raw-material resilience, qualify single-use supply chains, and align early with FDA, EMA, and local GMP expectations will be better positioned for commercial success.

Research Methodology

Research methodology is based on secondary research from publicly available regulatory, industry, scientific, and corporate sources, including health authority guidance, biomanufacturing standards, public disclosures, peer-reviewed literature, recognized trade data, and technical publications. Insights were cross-checked to ensure alignment with current bioprocessing trends and established evidence across biologics manufacturing, vaccine production, advanced therapies, and industrial fermentation.

The methodology evaluates technology adoption, regional manufacturing capacity, end-use demand, regulatory conditions, supply-chain resilience, and competitive dynamics. Qualitative assessment was applied to identify strategic themes in single-use systems, stainless-steel platforms, perfusion processing, automation, AI-enabled control, process analytical technology, GMP compliance, biologics manufacturing, and regional localization strategies across major bioreactor markets.

Conclusion

The bioreactors market is entering a new phase defined by flexible manufacturing, process intensification, automation, artificial intelligence, and regional capacity expansion. As biologics, biosimilars, vaccines, industrial biotechnology, and cell and gene therapies continue to advance, bioreactor performance is becoming a strategic determinant of cost, quality, speed, sterility assurance, and supply resilience.

Organizations that combine validated technology, digital process control, regulatory readiness, skilled talent, and robust supply networks will be best positioned to capture demand. The strongest opportunities will emerge where scalable bioprocessing platforms meet localized healthcare needs, resilient manufacturing strategies, and increasingly complex therapeutic pipelines.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Bioreactors Market, by Type
7.1. Introduction
7.2. Stirred-Tank Bioreactors
7.3. Membrane Bioreactors
7.4. Packed-Bed Bioreactors
7.5. Bubble-Column Bioreactors
7.6. Airlift Bioreactors
7.7. Fluidized-Bed Bioreactors
7.8. Photobioreactors
7.9. Rocking-Motion Bioreactors
8. Bioreactors Market, by Vessel
8.1. Introduction
8.2. Reusable Bioreactors
8.3. Single-Use Bioreactors
9. Bioreactors Market, by Material
9.1. Introduction
9.2. Stainless Steel
9.3. Plastic
9.4. Glass
10. Bioreactors Market, by Operation Mode
10.1. Introduction
10.2. Fed-Batch
10.3. Batch
10.4. Continuous
11. Bioreactors Market, by Biological System
11.1. Introduction
11.2. Animal Cells
11.2.1. CHO cells
11.2.2. HEK293 cells
11.2.3. Hybridoma cells
11.3. Microbial Systems
11.3.1. Bacterial cultures
11.3.2. Yeast cultures
11.4. Insect Cells
11.5. Plant Cells
12. Bioreactors Market, by Capacity
12.1. Introduction
12.2. 500-2000L
12.3. Between 10-500L
12.4. More Than 2000L
12.5. Less Than 10L
13. Bioreactors Market, by Mode of Operation
13.1. Introduction
13.2. Fed-Batch
13.3. Batch
13.4. Continuous
14. Bioreactors Market, by Application
14.1. Introduction
14.2. Biopharmaceutical Production
14.2.1. Therapeutic Proteins and Antibodies
14.2.2. Vaccines
14.2.3. Cell Therapies
14.2.4. Viral Vectors
14.2.5. Plasmid DNA and RNA
14.3. Environmental Treatment
14.3.1. Wastewater Treatment
14.3.2. Bioremediation
14.4. Industrial Biomanufacturing
14.4.1. Biofuels
14.4.2. Industrial Enzymes
14.4.3. Biopolymers and Biomaterials
14.4.4. Platform and Specialty Biochemicals
14.5. Food and Feed Production
14.5.1. Fermented Foods and Beverages
14.5.2. Food and Feed Ingredients
14.5.3. Cell-Cultured Foods
14.6. Research and Development
14.6.1. Process Development and Scale-Up
14.6.2. Cell and Strain Development
14.6.3. Discovery and Screening
15. Bioreactors Market, by End User
15.1. Introduction
15.2. Biopharmaceutical Manufacturers
15.3. Contract Research, Development, and Manufacturing Organizations
15.4. Environmental and Wastewater Operators
15.5. Industrial Biotechnology and Chemicals Companies
15.6. Food and Feed Manufacturers
15.7. Research Laboratories and Academic Institutions
16. Bioreactors Market, by Region
16.1. Introduction
16.2. Asia-Pacific
16.3. Europe
16.4. North America
16.5. Latin America
16.6. Middle East
16.7. Africa
17. Bioreactors Market, by Group
17.1. Introduction
17.2. NATO
17.3. G7
17.4. European Union
17.5. BRICS
17.6. ASEAN
17.7. GCC
18. Bioreactors Market, by Country
18.1. Introduction
18.2. United States
18.3. China
18.4. Japan
18.5. Germany
18.6. United Kingdom
18.7. South Korea
18.8. France
18.9. India
18.10. Brazil
18.11. Australia
18.12. Canada
18.13. Italy
18.14. Spain
18.15. Mexico
18.16. Russia
19. Competitive Landscape
19.1. Market Share Analysis, 2025
19.2. Market Concentration Analysis, 2025
19.2.1. Concentration Ratio (CR)
19.2.2. Herfindahl Hirschman Index (HHI)
19.3. Recent Developments & Impact Analysis, 2025
19.4. Product Portfolio Analysis, 2025
19.5. Benchmarking Analysis, 2025
20. Company Profiles
20.1. Sartorius AG
20.2. Thermo Fisher Scientific Inc.
20.3. Danaher Corporation
20.4. Merck KGaA
20.5. Veolia Environnement S.A.
20.6. Eppendorf SE
20.7. GEA Group Aktiengesellschaft
20.8. ABEC, Inc.
20.9. Morimatsu Life Sciences
20.10. Kubota Corporation
20.11. Tofflon Science and Technology Group Co., Ltd.
20.12. ZETA GmbH
20.13. Pierre Guérin SAS
20.14. Alfa Laval AB
20.15. PBS Biotech, Inc.
20.16. Donaldson Company, Inc.
20.17. Shanghai Duoning Biotechnology Co., Ltd.
20.18. Infors AG
20.19. DCI, Inc.
20.20. Esco Lifesciences Group Ltd.
20.21. ABLE Corporation
20.22. BIONET
20.23. Distek, Inc.
20.24. CerCell A/S
20.25. bbi-biotech GmbH
20.26. Solida Biotech GmbH
20.27. Satake MultiMix Corporation
20.28. Biofors Global Inc.
20.29. Subitec GmbH
20.30. BioSystemENG Co., Ltd.
20.31. Varicon Aqua Solutions Ltd.
20.32. Getinge AB
21. Key Experts
List of Figures
FIGURE 1. Global Bioreactors Market, Years Considered for the Study
FIGURE 2. Global Bioreactors Market, Research Design
FIGURE 3. Global Bioreactors Market, Research Framework
FIGURE 4. Global Bioreactors Market, Data Triangulation
FIGURE 5. Global Bioreactors Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Bioreactors Market Size, by Type, 2025 vs 2032 (%)
FIGURE 7. Global Bioreactors Market Size, by Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Bioreactors Market Size, by Vessel, 2025 vs 2032 (%)
FIGURE 9. Global Bioreactors Market Size, by Vessel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Bioreactors Market Size, by Material, 2025 vs 2032 (%)
FIGURE 11. Global Bioreactors Market Size, by Material, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Bioreactors Market Size, by Operation Mode, 2025 vs 2032 (%)
FIGURE 13. Global Bioreactors Market Size, by Operation Mode, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Bioreactors Market Size, by Biological System, 2025 vs 2032 (%)
FIGURE 15. Global Bioreactors Market Size, by Biological System, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Bioreactors Market Size, by Capacity, 2025 vs 2032 (%)
FIGURE 17. Global Bioreactors Market Size, by Capacity, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Bioreactors Market Size, by Mode of Operation, 2025 vs 2032 (%)
FIGURE 19. Global Bioreactors Market Size, by Mode of Operation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Bioreactors Market Size, by Application, 2025 vs 2032 (%)
FIGURE 21. Global Bioreactors Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Bioreactors Market Size, by End User, 2025 vs 2032 (%)
FIGURE 23. Global Bioreactors Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 24. Global Bioreactors Market Size, by Region, 2025 vs 2032 (%)
FIGURE 25. Global Bioreactors Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 26. Global Bioreactors Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 27. Global Bioreactors Market Size, by Country, 2025 vs 2032 (%)
FIGURE 28. Global Bioreactors Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 29. Global Bioreactors Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Bioreactors Market Segmentation & Coverage
TABLE 2. Global Bioreactors Market Size, 2017-2032 (USD Million)
TABLE 3. Global Bioreactors Market Size, by Type, 2017-2032 (USD Million)
TABLE 4. Global Stirred-Tank Bioreactors Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Stirred-Tank Bioreactors Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Stirred-Tank Bioreactors Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Membrane Bioreactors Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Membrane Bioreactors Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Membrane Bioreactors Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Packed-Bed Bioreactors Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Packed-Bed Bioreactors Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Packed-Bed Bioreactors Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Bubble-Column Bioreactors Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Bubble-Column Bioreactors Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Bubble-Column Bioreactors Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Airlift Bioreactors Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Airlift Bioreactors Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Airlift Bioreactors Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Fluidized-Bed Bioreactors Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Fluidized-Bed Bioreactors Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Fluidized-Bed Bioreactors Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Photobioreactors Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Photobioreactors Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Photobioreactors Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Rocking-Motion Bioreactors Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Rocking-Motion Bioreactors Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Rocking-Motion Bioreactors Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Bioreactors Market Size, by Vessel, 2017-2032 (USD Million)
TABLE 29. Global Reusable Bioreactors Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Reusable Bioreactors Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Reusable Bioreactors Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Single-Use Bioreactors Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Single-Use Bioreactors Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Single-Use Bioreactors Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Bioreactors Market Size, by Material, 2017-2032 (USD Million)
TABLE 36. Global Stainless Steel Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Stainless Steel Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Stainless Steel Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Plastic Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Plastic Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Plastic Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Glass Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Glass Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Glass Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Bioreactors Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 46. Global Fed-Batch Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Fed-Batch Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Fed-Batch Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Batch Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Batch Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Batch Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Continuous Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Continuous Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Continuous Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Bioreactors Market Size, by Biological System, 2017-2032 (USD Million)
TABLE 56. Global Animal Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Animal Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Animal Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global CHO cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global CHO cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global CHO cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global HEK293 cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global HEK293 cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global HEK293 cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Hybridoma cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Hybridoma cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Hybridoma cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Microbial Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Microbial Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Microbial Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Bacterial cultures Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Bacterial cultures Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Bacterial cultures Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Yeast cultures Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Yeast cultures Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Yeast cultures Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Insect Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Insect Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Insect Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Plant Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Plant Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Plant Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Bioreactors Market Size, by Capacity, 2017-2032 (USD Million)
TABLE 84. Global 500-2000L Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global 500-2000L Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global 500-2000L Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Between 10-500L Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Between 10-500L Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Between 10-500L Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global More Than 2000L Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global More Than 2000L Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global More Than 2000L Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Less Than 10L Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Less Than 10L Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Less Than 10L Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Bioreactors Market Size, by Mode of Operation, 2017-2032 (USD Million)
TABLE 97. Global Fed-Batch Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Fed-Batch Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Fed-Batch Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Batch Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Batch Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Batch Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Continuous Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Continuous Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Continuous Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Bioreactors Market Size, by Application, 2017-2032 (USD Million)
TABLE 107. Global Biopharmaceutical Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Biopharmaceutical Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Biopharmaceutical Production Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Therapeutic Proteins and Antibodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Therapeutic Proteins and Antibodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Therapeutic Proteins and Antibodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Cell Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Cell Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Cell Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Viral Vectors Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Viral Vectors Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Viral Vectors Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Plasmid DNA and RNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Plasmid DNA and RNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Plasmid DNA and RNA Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Environmental Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Environmental Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Environmental Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Wastewater Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Wastewater Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Wastewater Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Bioremediation Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Bioremediation Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Bioremediation Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Industrial Biomanufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Industrial Biomanufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Industrial Biomanufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Biofuels Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Global Biofuels Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. Global Biofuels Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. Global Industrial Enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Global Industrial Enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. Global Industrial Enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 143. Global Biopolymers and Biomaterials Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Global Biopolymers and Biomaterials Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. Global Biopolymers and Biomaterials Market Size, by Country, 2017-2032 (USD Million)
TABLE 146. Global Platform and Specialty Biochemicals Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Global Platform and Specialty Biochemicals Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. Global Platform and Specialty Biochemicals Market Size, by Country, 2017-2032 (USD Million)
TABLE 149. Global Food and Feed Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Global Food and Feed Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. Global Food and Feed Production Market Size, by Country, 2017-2032 (USD Million)
TABLE 152. Global Fermented Foods and Beverages Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Global Fermented Foods and Beverages Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. Global Fermented Foods and Beverages Market Size, by Country, 2017-2032 (USD Million)
TABLE 155. Global Food and Feed Ingredients Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Global Food and Feed Ingredients Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. Global Food and Feed Ingredients Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. Global Cell-Cultured Foods Market Size, by Region, 2017-2032 (USD Million)
TABLE 159. Global Cell-Cultured Foods Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. Global Cell-Cultured Foods Market Size, by Country, 2017-2032 (USD Million)
TABLE 161. Global Research and Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Global Research and Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. Global Research and Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 164. Global Process Development and Scale-Up Market Size, by Region, 2017-2032 (USD Million)
TABLE 165. Global Process Development and Scale-Up Market Size, by Group, 2017-2032 (USD Million)
TABLE 166. Global Process Development and Scale-Up Market Size, by Country, 2017-2032 (USD Million)
TABLE 167. Global Cell and Strain Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Global Cell and Strain Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. Global Cell and Strain Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 170. Global Discovery and Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 171. Global Discovery and Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 172. Global Discovery and Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 173. Global Bioreactors Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. Global Biopharmaceutical Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 175. Global Biopharmaceutical Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 176. Global Biopharmaceutical Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 177. Global Contract Research, Development, and Manufacturing Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 178. Global Contract Research, Development, and Manufacturing Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 179. Global Contract Research, Development, and Manufacturing Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 180. Global Environmental and Wastewater Operators Market Size, by Region, 2017-2032 (USD Million)
TABLE 181. Global Environmental and Wastewater Operators Market Size, by Group, 2017-2032 (USD Million)
TABLE 182. Global Environmental and Wastewater Operators Market Size, by Country, 2017-2032 (USD Million)
TABLE 183. Global Industrial Biotechnology and Chemicals Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 184. Global Industrial Biotechnology and Chemicals Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 185. Global Industrial Biotechnology and Chemicals Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 186. Global Food and Feed Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 187. Global Food and Feed Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 188. Global Food and Feed Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 189. Global Research Laboratories and Academic Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 190. Global Research Laboratories and Academic Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. Global Research Laboratories and Academic Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 192. Global Bioreactors Market Size, by Region, 2017-2032 (USD Million)
TABLE 193. Asia-Pacific Bioreactors Market Size, by Region, 2017-2032 (USD Million)
TABLE 194. Asia-Pacific Bioreactors Market Size, by Type, 2017-2032 (USD Million)
TABLE 195. Asia-Pacific Bioreactors Market Size, by Vessel, 2017-2032 (USD Million)
TABLE 196. Asia-Pacific Bioreactors Market Size, by Material, 2017-2032 (USD Million)
TABLE 197. Asia-Pacific Bioreactors Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 198. Asia-Pacific Bioreactors Market Size, by Biological System, 2017-2032 (USD Million)
TABLE 199. Asia-Pacific Bioreactors Market Size, by Animal Cells, 2017-2032 (USD Million)
TABLE 200. Asia-Pacific Bioreactors Market Size, by Microbial Systems, 2017-2032 (USD Million)
TABLE 201. Asia-Pacific Bioreactors Market Size, by Capacity, 2017-2032 (USD Million)
TABLE 202. Asia-Pacific Bioreactors Market Size, by Mode of Operation, 2017-2032 (USD Million)
TABLE 203. Asia-Pacific Bioreactors Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. Asia-Pacific Bioreactors Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 205. Asia-Pacific Bioreactors Market Size, by Environmental Treatment, 2017-2032 (USD Million)
TABLE 206. Asia-Pacific Bioreactors Market Size, by Industrial Biomanufacturing, 2017-2032 (USD Million)
TABLE 207. Asia-Pacific Bioreactors Market Size, by Food and Feed Production, 2017-2032 (USD Million)
TABLE 208. Asia-Pacific Bioreactors Market Size, by Research and Development, 2017-2032 (USD Million)
TABLE 209. Asia-Pacific Bioreactors Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. Europe Bioreactors Market Size, by Region, 2017-2032 (USD Million)
TABLE 211. Europe Bioreactors Market Size, by Type, 2017-2032 (USD Million)
TABLE 212. Europe Bioreactors Market Size, by Vessel, 2017-2032 (USD Million)
TABLE 213. Europe Bioreactors Market Size, by Material, 2017-2032 (USD Million)
TABLE 214. Europe Bioreactors Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 215. Europe Bioreactors Market Size, by Biological System, 2017-2032 (USD Million)
TABLE 216. Europe Bioreactors Market Size, by Animal Cells, 2017-2032 (USD Million)
TABLE 217. Europe Bioreactors Market Size, by Microbial Systems, 2017-2032 (USD Million)
TABLE 218. Europe Bioreactors Market Size, by Capacity, 2017-2032 (USD Million)
TABLE 219. Europe Bioreactors Market Size, by Mode of Operation, 2017-2032 (USD Million)
TABLE 220. Europe Bioreactors Market Size, by Application, 2017-2032 (USD Million)
TABLE 221. Europe Bioreactors Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 222. Europe Bioreactors Market Size, by Environmental Treatment, 2017-2032 (USD Million)
TABLE 223. Europe Bioreactors Market Size, by Industrial Biomanufacturing, 2017-2032 (USD Million)
TABLE 224. Europe Bioreactors Market Size, by Food and Feed Production, 2017-2032 (USD Million)
TABLE 225. Europe Bioreactors Market Size, by Research and Development, 2017-2032 (USD Million)
TABLE 226. Europe Bioreactors Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. North America Bioreactors Market Size, by Region, 2017-2032 (USD Million)
TABLE 228. North America Bioreactors Market Size, by Type, 2017-2032 (USD Million)
TABLE 229. North America Bioreactors Market Size, by Vessel, 2017-2032 (USD Million)
TABLE 230. North America Bioreactors Market Size, by Material, 2017-2032 (USD Million)
TABLE 231. North America Bioreactors Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 232. North America Bioreactors Market Size, by Biological System, 2017-2032 (USD Million)
TABLE 233. North America Bioreactors Market Size, by Animal Cells, 2017-2032 (USD Million)
TABLE 234. North America Bioreactors Market Size, by Microbial Systems, 2017-2032 (USD Million)
TABLE 235. North America Bioreactors Market Size, by Capacity, 2017-2032 (USD Million)
TABLE 236. North America Bioreactors Market Size, by Mode of Operation, 2017-2032 (USD Million)
TABLE 237. North America Bioreactors Market Size, by Application, 2017-2032 (USD Million)
TABLE 238. North America Bioreactors Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 239. North America Bioreactors Market Size, by Environmental Treatment, 2017-2032 (USD Million)
TABLE 240. North America Bioreactors Market Size, by Industrial Biomanufacturing, 2017-2032 (USD Million)
TABLE 241. North America Bioreactors Market Size, by Food and Feed Production, 2017-2032 (USD Million)
TABLE 242. North America Bioreactors Market Size, by Research and Development, 2017-2032 (USD Million)
TABLE 243. North America Bioreactors Market Size, by End User, 2017-2032 (USD Million)
TABLE 244. Latin America Bioreactors Market Size, by Region, 2017-2032 (USD Million)
TABLE 245. Latin America Bioreactors Market Size, by Type, 2017-2032 (USD Million)
TABLE 246. Latin America Bioreactors Market Size, by Vessel, 2017-2032 (USD Million)
TABLE 247. Latin America Bioreactors Market Size, by Material, 2017-2032 (USD Million)
TABLE 248. Latin America Bioreactors Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 249. Latin America Bioreactors Market Size, by Biological System, 2017-2032 (USD Million)
TABLE 250. Latin America Bioreactors Market Size, by Animal Cells, 2017-2032 (USD Million)
TABLE 251. Latin America Bioreactors Market Size, by Microbial Systems, 2017-2032 (USD Million)
TABLE 252. Latin America Bioreactors Market Size, by Capacity, 2017-2032 (USD Million)
TABLE 253. Latin America Bioreactors Market Size, by Mode of Operation, 2017-2032 (USD Million)
TABLE 254. Latin America Bioreactors Market Size, by Application, 2017-2032 (USD Million)
TABLE 255. Latin America Bioreactors Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 256. Latin America Bioreactors Market Size, by Environmental Treatment, 2017-2032 (USD Million)
TABLE 257. Latin America Bioreactors Market Size, by Industrial Biomanufacturing, 2017-2032 (USD Million)
TABLE 258. Latin America Bioreactors Market Size, by Food and Feed Production, 2017-2032 (USD Million)
TABLE 259. Latin America Bioreactors Market Size, by Research and Development, 2017-2032 (USD Million)
TABLE 260. Latin America Bioreactors Market Size, by End User, 2017-2032 (USD Million)
TABLE 261. Middle East Bioreactors Market Size, by Region, 2017-2032 (USD Million)
TABLE 262. Middle East Bioreactors Market Size, by Type, 2017-2032 (USD Million)
TABLE 263. Middle East Bioreactors Market Size, by Vessel, 2017-2032 (USD Million)
TABLE 264. Middle East Bioreactors Market Size, by Material, 2017-2032 (USD Million)
TABLE 265. Middle East Bioreactors Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 266. Middle East Bioreactors Market Size, by Biological System, 2017-2032 (USD Million)
TABLE 267. Middle East Bioreactors Market Size, by Animal Cells, 2017-2032 (USD Million)
TABLE 268. Middle East Bioreactors Market Size, by Microbial Systems, 2017-2032 (USD Million)
TABLE 269. Middle East Bioreactors Market Size, by Capacity, 2017-2032 (USD Million)
TABLE 270. Middle East Bioreactors Market Size, by Mode of Operation, 2017-2032 (USD Million)
TABLE 271. Middle East Bioreactors Market Size, by Application, 2017-2032 (USD Million)
TABLE 272. Middle East Bioreactors Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 273. Middle East Bioreactors Market Size, by Environmental Treatment, 2017-2032 (USD Million)
TABLE 274. Middle East Bioreactors Market Size, by Industrial Biomanufacturing, 2017-2032 (USD Million)
TABLE 275. Middle East Bioreactors Market Size, by Food and Feed Production, 2017-2032 (USD Million)
TABLE 276. Middle East Bioreactors Market Size, by Research and Development, 2017-2032 (USD Million)
TABLE 277. Middle East Bioreactors Market Size, by End User, 2017-2032 (USD Million)
TABLE 278. Africa Bioreactors Market Size, by Region, 2017-2032 (USD Million)
TABLE 279. Africa Bioreactors Market Size, by Type, 2017-2032 (USD Million)
TABLE 280. Africa Bioreactors Market Size, by Vessel, 2017-2032 (USD Million)
TABLE 281. Africa Bioreactors Market Size, by Material, 2017-2032 (USD Million)
TABLE 282. Africa Bioreactors Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 283. Africa Bioreactors Market Size, by Biological System, 2017-2032 (USD Million)
TABLE 284. Africa Bioreactors Market Size, by Animal Cells, 2017-2032 (USD Million)
TABLE 285. Africa Bioreactors Market Size, by Microbial Systems, 2017-2032 (USD Million)
TABLE 286. Africa Bioreactors Market Size, by Capacity, 2017-2032 (USD Million)
TABLE 287. Africa Bioreactors Market Size, by Mode of Operation, 2017-2032 (USD Million)
TABLE 288. Africa Bioreactors Market Size, by Application, 2017-2032 (USD Million)
TABLE 289. Africa Bioreactors Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 290. Africa Bioreactors Market Size, by Environmental Treatment, 2017-2032 (USD Million)
TABLE 291. Africa Bioreactors Market Size, by Industrial Biomanufacturing, 2017-2032 (USD Million)
TABLE 292. Africa Bioreactors Market Size, by Food and Feed Production, 2017-2032 (USD Million)
TABLE 293. Africa Bioreactors Market Size, by Research and Development, 2017-2032 (USD Million)
TABLE 294. Africa Bioreactors Market Size, by End User, 2017-2032 (USD Million)
TABLE 295. Global Bioreactors Market Size, by Group, 2017-2032 (USD Million)
TABLE 296. NATO Bioreactors Market Size, by Group, 2017-2032 (USD Million)
TABLE 297. NATO Bioreactors Market Size, by Type, 2017-2032 (USD Million)
TABLE 298. NATO Bioreactors Market Size, by Vessel, 2017-2032 (USD Million)
TABLE 299. NATO Bioreactors Market Size, by Material, 2017-2032 (USD Million)
TABLE 300. NATO Bioreactors Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 301. NATO Bioreactors Market Size, by Biological System, 2017-2032 (USD Million)
TABLE 302. NATO Bioreactors Market Size, by Animal Cells, 2017-2032 (USD Million)
TABLE 303. NATO Bioreactors Market Size, by Microbial Systems, 2017-2032 (USD Million)
TABLE 304. NATO Bioreactors Market Size, by Capacity, 2017-2032 (USD Million)
TABLE 305. NATO Bioreactors Market Size, by Mode of Operation, 2017-2032 (USD Million)
TABLE 306. NATO Bioreactors Market Size, by Application, 2017-2032 (USD Million)
TABLE 307. NATO Bioreactors Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 308. NATO Bioreactors Market Size, by Environmental Treatment, 2017-2032 (USD Million)
TABLE 309. NATO Bioreactors Market Size, by Industrial Biomanufacturing, 2017-2032 (USD Million)
TABLE 310. NATO Bioreactors Market Size, by Food and Feed Production, 2017-2032 (USD Million)
TABLE 311. NATO Bioreactors Market Size, by Research and Development, 2017-2032 (USD Million)
TABLE 312. NATO Bioreactors Market Size, by End User, 2017-2032 (USD Million)
TABLE 313. G7 Bioreactors Market Size, by Group, 2017-2032 (USD Million)
TABLE 314. G7 Bioreactors Market Size, by Type, 2017-2032 (USD Million)
TABLE 315. G7 Bioreactors Market Size, by Vessel, 2017-2032 (USD Million)
TABLE 316. G7 Bioreactors Market Size, by Material, 2017-2032 (USD Million)
TABLE 317. G7 Bioreactors Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 318. G7 Bioreactors Market Size, by Biological System, 2017-2032 (USD Million)
TABLE 319. G7 Bioreactors Market Size, by Animal Cells, 2017-2032 (USD Million)
TABLE 320. G7 Bioreactors Market Size, by Microbial Systems, 2017-2032 (USD Million)
TABLE 321. G7 Bioreactors Market Size, by Capacity, 2017-2032 (USD Million)
TABLE 322. G7 Bioreactors Market Size, by Mode of Operation, 2017-2032 (USD Million)
TABLE 323. G7 Bioreactors Market Size, by Application, 2017-2032 (USD Million)
TABLE 324. G7 Bioreactors Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 325. G7 Bioreactors Market Size, by Environmental Treatment, 2017-2032 (USD Million)
TABLE 326. G7 Bioreactors Market Size, by Industrial Biomanufacturing, 2017-2032 (USD Million)
TABLE 327. G7 Bioreactors Market Size, by Food and Feed Production, 2017-2032 (USD Million)
TABLE 328. G7 Bioreactors Market Size, by Research and Development, 2017-2032 (USD Million)
TABLE 329. G7 Bioreactors Market Size, by End User, 2017-2032 (USD Million)
TABLE 330. European Union Bioreactors Market Size, by Group, 2017-2032 (USD Million)
TABLE 331. European Union Bioreactors Market Size, by Type, 2017-2032 (USD Million)
TABLE 332. European Union Bioreactors Market Size, by Vessel, 2017-2032 (USD Million)
TABLE 333. European Union Bioreactors Market Size, by Material, 2017-2032 (USD Million)
TABLE 334. European Union Bioreactors Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 335. European Union Bioreactors Market Size, by Biological System, 2017-2032 (USD Million)
TABLE 336. European Union Bioreactors Market Size, by Animal Cells, 2017-2032 (USD Million)
TABLE 337. European Union Bioreactors Market Size, by Microbial Systems, 2017-2032 (USD Million)
TABLE 338. European Union Bioreactors Market Size, by Capacity, 2017-2032 (USD Million)
TABLE 339. European Union Bioreactors Market Size, by Mode of Operation, 2017-2032 (USD Million)
TABLE 340. European Union Bioreactors Market Size, by Application, 2017-2032 (USD Million)
TABLE 341. European Union Bioreactors Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 342. European Union Bioreactors Market Size, by Environmental Treatment, 2017-2032 (USD Million)
TABLE 343. European Union Bioreactors Market Size, by Industrial Biomanufacturing, 2017-2032 (USD Million)
TABLE 344. European Union Bioreactors Market Size, by Food and Feed Production, 2017-2032 (USD Million)
TABLE 345. European Union Bioreactors Market Size, by Research and Development, 2017-2032 (USD Million)
TABLE 346. European Union Bioreactors Market Size, by End User, 2017-2032 (USD Million)
TABLE 347. BRICS Bioreactors Market Size, by Group, 2017-2032 (USD Million)
TABLE 348. BRICS Bioreactors Market Size, by Type, 2017-2032 (USD Million)
TABLE 349. BRICS Bioreactors Market Size, by Vessel, 2017-2032 (USD Million)
TABLE 350. BRICS Bioreactors Market Size, by Material, 2017-2032 (USD Million)
TABLE 351. BRICS Bioreactors Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 352. BRICS Bioreactors Market Size, by Biological System, 2017-2032 (USD Million)
TABLE 353. BRICS Bioreactors Market Size, by Animal Cells, 2017-2032 (USD Million)
TABLE 354. BRICS Bioreactors Market Size, by Microbial Systems, 2017-2032 (USD Million)
TABLE 355. BRICS Bioreactors Market Size, by Capacity, 2017-2032 (USD Million)
TABLE 356. BRICS Bioreactors Market Size, by Mode of Operation, 2017-2032 (USD Million)
TABLE 357. BRICS Bioreactors Market Size, by Application, 2017-2032 (USD Million)
TABLE 358. BRICS Bioreactors Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 359. BRICS Bioreactors Market Size, by Environmental Treatment, 2017-2032 (USD Million)
TABLE 360. BRICS Bioreactors Market Size, by Industrial Biomanufacturing, 2017-2032 (USD Million)
TABLE 361. BRICS Bioreactors Market Size, by Food and Feed Production, 2017-2032 (USD Million)
TABLE 362. BRICS Bioreactors Market Size, by Research and Development, 2017-2032 (USD Million)
TABLE 363. BRICS Bioreactors Market Size, by End User, 2017-2032 (USD Million)
TABLE 364. ASEAN Bioreactors Market Size, by Group, 2017-2032 (USD Million)
TABLE 365. ASEAN Bioreactors Market Size, by Type, 2017-2032 (USD Million)
TABLE 366. ASEAN Bioreactors Market Size, by Vessel, 2017-2032 (USD Million)
TABLE 367. ASEAN Bioreactors Market Size, by Material, 2017-2032 (USD Million)
TABLE 368. ASEAN Bioreactors Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 369. ASEAN Bioreactors Market Size, by Biological System, 2017-2032 (USD Million)
TABLE 370. ASEAN Bioreactors Market Size, by Animal Cells, 2017-2032 (USD Million)
TABLE 371. ASEAN Bioreactors Market Size, by Microbial Systems, 2017-2032 (USD Million)
TABLE 372. ASEAN Bioreactors Market Size, by Capacity, 2017-2032 (USD Million)
TABLE 373. ASEAN Bioreactors Market Size, by Mode of Operation, 2017-2032 (USD Million)
TABLE 374. ASEAN Bioreactors Market Size, by Application, 2017-2032 (USD Million)
TABLE 375. ASEAN Bioreactors Mar

Companies Mentioned

  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • Veolia Environnement S.A.
  • Eppendorf SE
  • GEA Group Aktiengesellschaft
  • ABEC, Inc.
  • Morimatsu Life Sciences
  • Kubota Corporation
  • Tofflon Science and Technology Group Co., Ltd.
  • ZETA GmbH
  • Pierre Guérin SAS
  • Alfa Laval AB
  • PBS Biotech, Inc.
  • Donaldson Company, Inc.
  • Shanghai Duoning Biotechnology Co., Ltd.
  • Infors AG
  • DCI, Inc.
  • Esco Lifesciences Group Ltd.
  • ABLE Corporation
  • BIONET
  • Distek, Inc.
  • CerCell A/S
  • bbi-biotech GmbH
  • Solida Biotech GmbH
  • Satake MultiMix Corporation
  • Biofors Global Inc.
  • Subitec GmbH
  • BioSystemENG Co., Ltd.
  • Varicon Aqua Solutions Ltd.
  • Getinge AB

Table Information

Report AttributeDetails
No. of Pages187
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 14.62 Billion
Forecasted Market Value ( USD ) by 2032 $ 22.21 Billion
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned32

Related Topics

Related Reports

Single-Use Bioreactors Market - Global Forecast 2026-2032 - Product Image

Single-Use Bioreactors Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Membrane Bioreactor Market - Global Forecast 2026-2032 - Product Image

Membrane Bioreactor Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Bioreactors Market Size, Share, Trends, and Forecast by Type, Usage, Scale, Control Type, and Region, 2026-2034 - Product Image

Bioreactors Market Size, Share, Trends, and Forecast by Type, Usage, Scale, Control Type, and Region, 2026-2034

  • Report
  • 143 Pages
  • Global
From
Single-Use Bioreactors - Global Strategic Business Report - Product Image

Single-Use Bioreactors - Global Strategic Business Report

  • Report
  • 412 Pages
  • Global
From
Single-Use Bioreactors Market by Product, Type, Cell Type, Molecule, Process Mode, Application, Competition, Region - Global Forecast to 2031 - Product Image

Single-Use Bioreactors Market by Product, Type, Cell Type, Molecule, Process Mode, Application, Competition, Region - Global Forecast to 2031

  • Report
  • 477 Pages
  • Global
From

About the Market

The bioreactor market is a subset of the biotechnology industry, focusing on the production of biological materials such as proteins, enzymes, and other biomolecules. Bioreactors are used to cultivate cells, microorganisms, and other biological materials in a controlled environment. They are used in a variety of industries, including pharmaceuticals, food and beverage, and environmental engineering. Bioreactors are designed to provide optimal conditions for the growth and production of biological materials. They are equipped with sensors and controllers to monitor and adjust the environment, such as temperature, pH, and oxygen levels. Additionally, bioreactors can be used to produce a variety of products, including vaccines, antibiotics, and enzymes. The bioreactor market is expected to grow in the coming years due to increasing demand for biotechnology products. Additionally, advances in technology are making bioreactors more efficient and cost-effective. Some companies in the bioreactor market include Thermo Fisher Scientific, Sartorius AG, Merck KGaA, Eppendorf AG, and GE Healthcare. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.